These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 19042177

  • 61. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 62. Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.
    Mileshkin L, Hicks RJ, Hughes BG, Mitchell PL, Charu V, Gitlitz BJ, Macfarlane D, Solomon B, Amler LC, Yu W, Pirzkall A, Fine BM.
    Clin Cancer Res; 2011 May 15; 17(10):3304-15. PubMed ID: 21364032
    [Abstract] [Full Text] [Related]

  • 63. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW, Na JO, Kang DY, Lee SY, Lee SM.
    Clin Lung Cancer; 2017 Mar 15; 18(2):198-206. PubMed ID: 27495385
    [Abstract] [Full Text] [Related]

  • 64. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
    Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.
    Thorax; 1997 May 15; 52(5):438-41. PubMed ID: 9176535
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. FDG-PET demonstration of asymptomatic skeletal muscle metastasis from colorectal carcinoma.
    Hattori H, Nishimura H, Matsuoka H, Yamamoto K.
    J Orthop Sci; 2008 Sep 15; 13(5):481-4. PubMed ID: 18843466
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
    Turan O, Ozdogan O, Gurel D, Onen A, Kargi A, Sevinc C.
    Clin Respir J; 2013 Jan 15; 7(1):e1-5. PubMed ID: 22129499
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT.
    Sarma M, Sonik B, Subramanyam P, Sundaram PS.
    J Egypt Natl Canc Inst; 2015 Mar 15; 27(1):47-50. PubMed ID: 25698468
    [Abstract] [Full Text] [Related]

  • 76. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ.
    Radiother Oncol; 2000 Jun 15; 55(3):317-24. PubMed ID: 10869746
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul 15; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 80. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA.
    Chest; 2006 Feb 15; 129(2):393-401. PubMed ID: 16478857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.